title: How many patients with ischemic cardiomyopathy exhibit viable myocardium?
authors.affiliation: Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. arendschinkel@hetnet.nl
authors.forename: A F
authors.initials: AF
authors.lastname: Schinkel
authors.forename: J J
authors.initials: JJ
authors.lastname: Bax
authors.forename: E
authors.initials: E
authors.lastname: Boersma
authors.forename: A
authors.initials: A
authors.lastname: Elhendy
authors.forename: J R
authors.initials: JR
authors.lastname: Roelandt
authors.forename: D
authors.initials: D
authors.lastname: Poldermans
mesh_terms: D000368:Aged; D015897:Comorbidity; D018450:Disease Progression; D004280:Dobutamine; D015150:Echocardiography, Doppler / Q000379:methods; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000000981:diagnostic imaging* / Q000453:epidemiology*; D006334:Heart Function Tests; D006339:Heart Rate; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging* / Q000453:epidemiology*; D009206:Myocardium; D015995:Prevalence; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D013318:Stroke Volume; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging* / Q000453:epidemiology*
chemical_list: D004280:Dobutamine